These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 31171701)

  • 1. Dedifferentiation by adenovirus E1A due to inactivation of Hippo pathway effectors YAP and TAZ.
    Zemke NR; Gou D; Berk AJ
    Genes Dev; 2019 Jul; 33(13-14):828-843. PubMed ID: 31171701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I collagen deposition via osteoinduction ameliorates YAP/TAZ activity in 3D floating culture clumps of mesenchymal stem cell/extracellular matrix complexes.
    Komatsu N; Kajiya M; Motoike S; Takewaki M; Horikoshi S; Iwata T; Ouhara K; Takeda K; Matsuda S; Fujita T; Kurihara H
    Stem Cell Res Ther; 2018 Dec; 9(1):342. PubMed ID: 30526677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1.
    Hansen CG; Ng YL; Lam WL; Plouffe SW; Guan KL
    Cell Res; 2015 Dec; 25(12):1299-313. PubMed ID: 26611634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus small E1A directs activation of Alu transcription at YAP/TEAD- and AP-1-bound enhancers through interactions with the EP400 chromatin remodeler.
    Cantarella S; Vezzoli M; Carnevali D; Morselli M; Zemke NR; Montanini B; Daussy CF; Wodrich H; Teichmann M; Pellegrini M; Berk AJ; Dieci G; Ferrari R
    Nucleic Acids Res; 2024 Sep; 52(16):9481-9500. PubMed ID: 39011896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
    Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
    Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ.
    Zhang Z; Du J; Wang S; Shao L; Jin K; Li F; Wei B; Ding W; Fu P; van Dam H; Wang A; Jin J; Ding C; Yang B; Zheng M; Feng XH; Guan KL; Zhang L
    Mol Cell; 2019 Jan; 73(1):7-21.e7. PubMed ID: 30472188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippo pathway-independent restriction of TAZ and YAP by angiomotin.
    Chan SW; Lim CJ; Chong YF; Pobbati AV; Huang C; Hong W
    J Biol Chem; 2011 Mar; 286(9):7018-26. PubMed ID: 21224387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.
    Kim M; Kim T; Johnson RL; Lim DS
    Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifaceted regulation and functions of YAP/TAZ in tumors (Review).
    Liu H; Du S; Lei T; Wang H; He X; Tong R; Wang Y
    Oncol Rep; 2018 Jul; 40(1):16-28. PubMed ID: 29749524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation.
    Kim MH; Kim J; Hong H; Lee SH; Lee JK; Jung E; Kim J
    EMBO J; 2016 Mar; 35(5):462-78. PubMed ID: 26668268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP and TAZ are essential for basal and squamous cell carcinoma initiation.
    Debaugnies M; Sánchez-Danés A; Rorive S; Raphaël M; Liagre M; Parent MA; Brisebarre A; Salmon I; Blanpain C
    EMBO Rep; 2018 Jul; 19(7):. PubMed ID: 29875149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ.
    Edwards DN; Ngwa VM; Wang S; Shiuan E; Brantley-Sieders DM; Kim LC; Reynolds AB; Chen J
    Sci Signal; 2017 Dec; 10(508):. PubMed ID: 29208682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common and Distinctive Functions of the Hippo Effectors Taz and Yap in Skeletal Muscle Stem Cell Function.
    Sun C; De Mello V; Mohamed A; Ortuste Quiroga HP; Garcia-Munoz A; Al Bloshi A; Tremblay AM; von Kriegsheim A; Collie-Duguid E; Vargesson N; Matallanas D; Wackerhage H; Zammit PS
    Stem Cells; 2017 Aug; 35(8):1958-1972. PubMed ID: 28589555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of YAP, TAZ and HSP90 in contact guidance and intercellular junction formation in corneal epithelial cells.
    Raghunathan VK; Dreier B; Morgan JT; Tuyen BC; Rose BW; Reilly CM; Russell P; Murphy CJ
    PLoS One; 2014; 9(10):e109811. PubMed ID: 25290150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) mediate cell density-dependent proinflammatory responses.
    Zhang Q; Han X; Chen J; Xie X; Xu J; Zhao Y; Shen J; Hu L; Xu P; Song H; Zhang L; Zhao B; Wang YJ; Xia Z
    J Biol Chem; 2018 Nov; 293(47):18071-18085. PubMed ID: 30315101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ.
    Mesrouze Y; Meyerhofer M; Bokhovchuk F; Fontana P; Zimmermann C; Martin T; Delaunay C; Izaac A; Kallen J; Schmelzle T; Erdmann D; Chène P
    Protein Sci; 2017 Dec; 26(12):2399-2409. PubMed ID: 28960584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAZ and YAP are frequently activated oncoproteins in sarcomas.
    Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR
    Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis.
    Liu F; Lagares D; Choi KM; Stopfer L; Marinković A; Vrbanac V; Probst CK; Hiemer SE; Sisson TH; Horowitz JC; Rosas IO; Fredenburgh LE; Feghali-Bostwick C; Varelas X; Tager AM; Tschumperlin DJ
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L344-57. PubMed ID: 25502501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP/TAZ enhance mammalian embryonic neural stem cell characteristics in a Tead-dependent manner.
    Han D; Byun SH; Park S; Kim J; Kim I; Ha S; Kwon M; Yoon K
    Biochem Biophys Res Commun; 2015 Feb; 458(1):110-6. PubMed ID: 25634692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1.
    Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X
    Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.